ロード中...
Rebound-associated vertebral fractures after denosumab discontinuation in a lung cancer patient with bone metastases
Denosumab is a commonly used antiresorptive treatment in patients with osteoporosis or solid tumours with bone metastases. Upon denosumab discontinuation, a rebound phenomenon can occur that results in an increased (vertebral) fracture risk. This phenomenon is well-known in the setting of osteoporos...
保存先:
| 主要な著者: | , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2022-06-01
|
| シリーズ: | Bone Reports |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S2352187222004168 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|